GRAIL, Inc. Payments to Acquire Marketable Securities
GRAIL, Inc. (GRAL) reported Payments to Acquire Marketable Securities of $800.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- GRAIL, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $462.44M, a 64.01% increase year-over-year.
- GRAIL, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $337.83M, a 53.19% increase year-over-year.
- GRAIL, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $566.41M, a 3.78% increase year-over-year.
- GRAIL, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $239.44M.
- GRAIL, Inc. payments to acquire marketable securities for fiscal 2025 was $1.31B, a 139.71% increase from fiscal 2024.
- GRAIL, Inc. payments to acquire marketable securities for fiscal 2024 was $545.80M.
- GRAIL, Inc. payments to acquire marketable securities for fiscal 2023 was $0.00.
- GRAIL, Inc. payments to acquire marketable securities for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $462.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $800.28M 10-Q · filed 2026-08-06 | $1.37B derived: sum of 3 quarters · filed 2026-08-06 | $1.61B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $337.83M 10-Q · filed 2026-05-07 | $904.24M derived: sum of 2 quarters · filed 2026-05-07 | $1.14B derived: sum of 3 quarters · filed 2026-05-07 | $1.43B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $566.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $805.85M derived: sum of 2 quarters · filed 2026-03-12 | $1.09B derived: sum of 3 quarters · filed 2026-08-06 | $1.31B 10-K · filed 2026-03-12 |
| 2025-09-30 | $239.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $521.40M derived: sum of 2 quarters · filed 2026-08-06 | $741.93M 10-Q · filed 2025-11-13 | $1.29B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $281.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $502.49M 10-Q · filed 2026-08-06 | $1.05B derived: sum of 3 quarters · filed 2026-08-06 | $1.05B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $220.53M 10-Q · filed 2026-05-07 | $766.33M derived: sum of 2 quarters · filed 2026-05-07 | $766.33M derived: sum of 3 quarters · filed 2026-05-07 | $766.33M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $545.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $545.80M derived: sum of 2 quarters · filed 2026-03-12 | $545.80M derived: sum of 3 quarters · filed 2026-03-12 | $545.80M 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $0.00 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |